Aisling Capital IV LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:26 pm Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
Aisling Capital IV LP | 2,913,005 4.920% |
34,709 (+1.21%) |
Filing |
| 2024-02-06 4:15 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Aisling Capital IV LP | 2,878,296 6.800% |
1,735 (+0.06%) |
Filing |
| 2023-02-08 5:00 pm Purchase |
2022-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Aisling Capital IV LP | 2,876,561 12.340% |
10,413 (+0.36%) |
Filing |
| 2022-02-14 12:16 pm Purchase |
2021-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Aisling Capital IV LP | 2,866,148 12.330% |
2,866,148 (New Position) |
Filing |